Clinical Trial Update: A Study of MVA85A in Healthy Children and Infants [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the MVA85A tuberculosis vaccine in healthy children and infants has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED